Difficult diagnosis and localization of focal nesidioblastosis: clinical implications of ⁶⁸Gallium-DOTA-D-Phe¹-Tyr³-octreotide PET scanning
Annals of Surgical Treatment and Research
; : 51-55, 2016.
Article
in En
| WPRIM
| ID: wpr-135116
Responsible library:
WPRO
ABSTRACT
Focal nesidioblastosis is a rare cause of endogenous hyperinsulinemic hypoglycemia in adults. Because it is difficult to localize and detect with current imaging modalities, nesidioblastosis is challenging for biliary-pancreatic surgeons. ⁶⁸Gallium-DOTA-D-Phe¹-Tyr³-octreotide PET scanning and ¹¹¹indium-pentetreotide diethylene triamine pentaacetic acid octreotide scanning may be superior to conventional imaging modalities in determining the localization of nesidioblastosis. We report the successful surgical treatment of a 54-year-old woman with focal hyperplasia of the islets of Langerhans, who experienced frequent hypoglycemic symptoms and underwent various diagnostic examinations with different results.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Octreotide
/
Islets of Langerhans
/
Nesidioblastosis
/
Positron-Emission Tomography
/
Diagnosis
/
Surgeons
/
Hyperplasia
/
Hypoglycemia
Type of study:
Diagnostic_studies
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Annals of Surgical Treatment and Research
Year:
2016
Type:
Article